Our products utilize a proprietary, dual-carrier transdermal drug delivery system, we call:
Advanced Penetration Technology™ (APT™)
APT™ has solved the absorption problem that has hindered previous attempts with enabling topically applied medications to penetrate the epidermis into the dermis and surrounding tissues safely. The APT™ within our lead product, Tetracycline 3% ointment, operates by disrupting the cell wall of the organism and flooding the organism with medication, causing a biochemical and mechanical kill of the organism.
APT™ has the added benefit of optimizing the local tissue environment for a more rapid healing process. APT™ dramatically improves penetration of many topical medications, allowing for maximal effectiveness of our topically applied products. The APT™ will be a key aspect of all our product offerings brought into the consumer healthcare marketplace.
Validating APT™ efficacy with GLP Laboratory Tests
We are happy to share our testing results under a confidentiality agreement.
Learn more about our products that utilize APT™.